METERGOLINE FOR THE TREATMENT OF PSEUDOPR EGNANCY AND FOR THE INTERRUPTION OF LACTATION IN THE BITCH

Citation
K. Arbeiter et al., METERGOLINE FOR THE TREATMENT OF PSEUDOPR EGNANCY AND FOR THE INTERRUPTION OF LACTATION IN THE BITCH, Kleintierpraxis, 40(6), 1995, pp. 421
Citations number
NO
Categorie Soggetti
Veterinary Sciences
Journal title
ISSN journal
00232076
Volume
40
Issue
6
Year of publication
1995
Database
ISI
SICI code
0023-2076(1995)40:6<421:MFTTOP>2.0.ZU;2-S
Abstract
Metergoline, a prolactin inhibitor, serotonin antagonist and dopamine agonist, was used to treat 179 pseudopregnant bitches: 1978/79 in 36 p atients in Bremen (A), in 68 bitches in Vienna (B) and 52 bitches in M unich (C), using a dose of 200 mu g/kg body weight (BW) b.i.d., and in 1993/94 in 23 patients in Hannover (D) with a dose of 100 mu g/kg BW b.i.d. Metergoline was found effective at both dose levels, treatment resulting in a significant acceleration of the return to normalcy rega rding mammary gland regression, cessation of mammary gland secretion a nd return to normal behavior. Bromocriptine (10 mu g/kg BW) was used i n study D (a blinded trial) as a positive control (n=17) and was found equally effective, while lactose as a negative control (n=10) showed the somewhat stower spontaneous resolutions of the clinical symptoms o f pseudopregnancy. Duration of treatment with metergoline was 6.9 days (5.7 to 8.4 days) and the treatment effect (significant reduction of symptoms or normalization) was 79.9 % (63.8 % to 100 %). Observations of side effects included vomiting in 15 % (30 % following use of bromo criptine) and severe disturbances of behaviour of central nervous orig in in 50 % of all bitches treated with metergoline. This caused cessat ion of treatment in 25.7 % of all patients. The higher dose in studies A to C may have contributed to these disturbances. Metergoline when u sed to interrupt lactation following sectio porro (cesarian section an d simultaneous ovariohysterectomy) was fully effective within 5.3 to 7 .8 days and with this population, behavioural disturbances were seen l ess often (8.3 %). It remains unclear if there is a dose of metergolin e which is clinically effective but free of these side effects.